Kiniksa Pharmaceuticals International, plc
KNSA
Rank in Stocks
#2912
Kiniksa Pharmaceuticals International, plc, a biopharmaceutical company,... Kiniksa Pharmaceuticals International, plc, a biopharmaceutical company, develops and commercializes medical therapies in the United States, the United Kingdom, and internationally. The company offers ARCALYST, an interleukin-1alpha and 1beta cytokine trap for the treatment of recurrent pericarditis, a chronic autoinflammatory cardiovascular disease and cardiac sarcoidosis. It also develops KPL-387, an investigational and fully human immunoglobulin G2 monoclonal antibody, which is Phase 2/3 clinical trial for the treatment of recurrent pericarditis; and KPL-116, a Fc-modified immunoglobulin G2 monoclonal antibody, which is in pre-clinical stage. The company was formerly known as Kiniksa Pharmaceuticals, Ltd. and changed its name to Kiniksa Pharmaceuticals International, plc in June 2024. Kiniksa Pharmaceuticals International, plc was incorporated in 2015 and is based in London, the United Kingdom.
Share Price
$82.30
Market Cap
$6.42B
Change (1 day)
3.55%
Change (1 year)
111.08%
Country
GB
Trade Kiniksa Pharmaceuticals International, plc (KNSA)
Category
Healthcare
P/B ratio for Kiniksa Pharmaceuticals International, plc (KNSA)
P/B ratio as of October 2026 TTM: 9.35
According to Kiniksa Pharmaceuticals International, plc latest financial reports and stock price the company's current price-to-book ratio (TTM) is 9.35. At the end of 2023 the company had a P/B ratio of 2.80.
P/B ratio history for Kiniksa Pharmaceuticals International, plc from 2016 to 2026
P/B ratio at the end of each year
| Year | P/B Ratio | Change |
|---|---|---|
| 2026 (TTM) | 9.35 | 190.37% |
| 2024 | 3.22 | 15.07% |
| 2023 | 2.80 | -232.57% |
| 2022 | -2.11 | 76.75% |
| 2021 | -1.20 | -43.41% |
| 2020 | -2.11 | 25.79% |
| 2019 | -1.68 | -60.72% |
| 2018 | -4.27 | -39.36% |
| 2017 | -7.05 | -71.32% |
| 2016 | -24.57 | 0.00% |
P/B ratio for similar companies or competitors
| Company | P/B Ratio | P/B Ratio Difference | Country |
|---|---|---|---|
| 3.8424 | -58.90% |
US
|
|
| - | - |
SE
|
|
| - | - |
FR
|
|
| - | - |
IT
|
|
| 17.3539 | 85.61% |
US
|
